* Tectonic Therapeutic Inc TECX.OQ TECX.O is expected
to show
no change in quarterly revenue when it reports results on
August 8 (estimated) for the period ending January 1 0001
*
* LSEG's mean analyst estimate for Tectonic Therapeutic Inc
is
for a loss of $1.50 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Tectonic
Therapeutic Inc is $62.50, above its last closing price
of $16.91.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2024 -4.32 -4.32 -1.80 Beat 58.3
Dec. 31 2024 -4.95 -4.04 -2.40 Beat 40.6
Sep. 30 2023 -3.34 -3.40 -5.28 Missed -55.3
Jan. 1 0001 -2.48 -0.90 -4.44 Missed -395
Mar. -6.50 -6.54 -6.84 Missed -4.6
31 2023
Jan. 1 0001 -5.91 -6.84 Missed -15.7
Sep. 30 2022 -6.82 -6.60 -6.24 Beat 5.5
Jun. 30 2022 -7.07 -6.87 -7.68 Missed -11.8
This summary was machine generated August 7 at 02:01 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)